Current status of diagnosis and management of prediabetes at Hai phong Medical University hospital in 2023

Tóm tắt

Objectives: To evaluate the current status of diagnosis and management of prediabetes at Hai Phong Medical University Hospital in 2023. Method: A cross-sectional study was conducted on 214 patients with prediabetes (126 men, 88 women; mean age 67.1 ± 8.5 years) who attended Hai Phong Medical University Hospital between January and October 2023. Data on diagnostic tests, clinical characteristics, and treatment modalities were collected and analyzed according to the American Diabetes Association (ADA) and Vietnamese Ministry of Health guidelines [1,7]. Results: All patients were diagnosed with prediabetes based on fasting plasma glucose, while only 15.9% underwent HbA1c testing and 1.4% received an oral glucose tolerance test (OGTT). Screening for pharmacological treatment criteria was incomplete: BMI was assessed in 29.4% of patients, HbA1c in 17.3%, and family history in 27.6%. Among those evaluated, 91.1% met at least one ADA-recommended criterion for pharmacological therapy. However, only 1.4% received metformin, while 98.6% were managed with lifestyle modification alone. Conclusions: The diagnosis and management of prediabetes at Hai Phong Medical University Hospital did not fully adhere to international and national guidelines [1,2,7]. Underutilization of HbA1c and OGTT, incomplete risk factor assessment, and limited pharmacological intervention highlight the need for improved adherence to evidence-based recommendations to prevent progression to type 2 diabetes [8,10].